The pigmentation may have started somewhere else. A breakout that left a mark. A hormonal shift that brought melasma to the surface. A cluster of spots that built slowly over years of sun exposure. But then summer came, or a holiday happened, or a stretch of outdoor time without adequate protection, and the marks got darker. Noticeably darker. Darker than they were before the exposure, and not fading back.
That darkening is not a new condition. It is the existing condition responding to a trigger. UV radiation and heat are the two most potent environmental activators of melanocyte activity, and they do not create pigmentation from nothing. They amplify what is already there. They reactivate melanocytes that were beginning to quiet down. They deepen marks that were starting to fade.
The treatment priority is different from treating a dark mark in stable skin. Here, the trigger is ongoing or recent, and addressing it comes before any brightening product makes sense. Protection and trigger removal first. Fading second.
Why UV and Heat Are Treated Together
UV radiation and heat exposure are separate triggers with separate mechanisms, but they almost always overlap in practice.
A day outdoors involves both. A car ride in direct sunlight involves both. Cooking over a hot surface near a window involves both. Even indoor visible light exposure from screens is often paired with ambient heat from the devices or the environment. Treating one while ignoring the other leaves a trigger in place.
UV stimulates melanocytes directly through photobiological pathways. It also generates reactive oxygen species and DNA damage that sustain melanocyte overproduction beyond the moment of exposure.
Heat stimulates melanocytes through a separate, non-UV pathway. It does not require sunlight. Saunas, hot yoga, steam facials, prolonged cooking, and even sustained exercise in hot conditions can darken pigmentation independently of UV. Heat-induced pigmentation is less well-known but increasingly documented, particularly in melasma.
The practical implication: sun protection alone does not cover the full trigger profile. A broad-spectrum sunscreen blocks UV. It does not block heat. Managing both requires behavioural changes alongside product use.
Phase One: Remove and Reduce the Trigger
If the darkening is recent and clearly linked to UV or heat exposure, the first priority is stopping the exposure from continuing to drive the pigmentation deeper.
This is not the same as starting a brightening routine. A brightening routine applied to skin that is still being exposed daily to unprotected UV is working against a current it cannot outpace. The melanocytes are being activated faster than any serum can suppress them. The trigger has to be addressed before the treatment can gain traction.
Daily sun protection. Broad-spectrum SPF 30 or higher, applied every morning, reapplied every 2 hours during sustained exposure. This is the single intervention that matters most. Without it, nothing else in the treatment works. For pigmentation that has been recently activated by UV, the threshold for melanocyte stimulation is lower than normal. Even moderate sun exposure that would not darken healthy skin can re-darken sensitised marks.
Visible light protection. Standard sunscreens filter UV but not visible light in the 400 to 700nm range. For pigmentation that is actively responding to light exposure, particularly melasma, an iron oxide-tinted sunscreen provides additional protection against visible light-driven melanogenesis. This is a meaningful upgrade for anyone whose pigmentation worsens despite consistent UV-only protection.
Heat avoidance. Reduce direct heat to the face where practical. This includes steam from cooking, hot showers directed at the face, steam facials, saunas, and prolonged close-range heat from ovens or grills. It also includes sustained exercise in extreme heat without cooling. These are not extreme lifestyle changes. They are adjustments that reduce a trigger most people do not realise is relevant.
Shade and physical barriers. Hats with a wide brim reduce UV and heat reaching the face more effectively than sunscreen alone. Seeking shade during peak UV hours (10am to 4pm) is a straightforward reduction in total exposure. Sunscreen is the baseline. Physical protection is what raises the ceiling.
This phase does not have an end date. It becomes the permanent foundation under everything that follows.
Phase Two: Stabilise
Once the trigger exposure has been reduced, the skin needs time to settle before active treatment begins. Melanocytes that have been recently stimulated by UV or heat are in an elevated state of reactivity. Introducing aggressive brightening products or exfoliants into that environment risks provoking the same overreaction the trigger caused.
This stabilisation phase is shorter than the calming phase for inflammatory PIH from acne or eczema, because the trigger here is environmental rather than dermatological. The skin is not damaged in the same way. But the melanocytes are sensitised, and the products introduced during this window should reflect that.
Barrier support maintains the skin's integrity while melanocyte activity settles. Ceramides, gentle moisturisers, and hydrating serums keep the skin stable without provoking it.
Niacinamide can be introduced early. At 5% to 10%, it interrupts melanin transfer, supports the barrier, and reduces inflammation. It is well tolerated across skin tones and does not carry the irritation risk of acids or retinoids. For UV-activated pigmentation, it is a sensible first active because it works without accelerating turnover on sensitised skin.
Antioxidant support. Topical vitamin C serves a dual role here: it is a tyrosinase inhibitor that suppresses melanin production, and it is an antioxidant that helps neutralise the reactive oxygen species generated by UV exposure. Applied in the morning under sunscreen, it adds a layer of protection against ongoing oxidative damage.
Two to four weeks of this stabilisation routine, combined with rigorous sun and heat protection, creates the conditions under which more active treatment can work.
Phase Three: Fade
Once the skin is protected, stable, and no longer actively reacting to recent exposure, the full topical toolkit can be introduced.
Tyrosinase inhibitors beyond vitamin C can be layered in. Tranexamic acid, arbutin, kojic acid, or licorice extract add complementary suppression of melanin production. One or two well-chosen inhibitors used consistently will outperform a rotation of four used intermittently.
Exfoliants accelerate the shedding of pigmented cells. A gentle AHA (mandelic or lactic acid at low to moderate concentration) used two to three times a week supports turnover without the irritation risk of daily high-concentration acids. Glycolic acid is effective but more irritating; it is better suited to skin that has fully stabilised and has no residual sensitivity from the UV or heat event.
Retinoids increase epidermal turnover and push pigmented cells to the surface faster. Start low (0.25% retinol, two to three nights a week) and build. The retinisation adjustment phase carries its own irritation risk, and skin that has recently been UV-sensitised is more reactive to that irritation than skin that has been stable for months.
Prescription escalation follows the same logic as for any other PIH. If consistent topical treatment for 3 to 6 months has plateaued, prescription-strength tretinoin, azelaic acid, or hydroquinone can push further. For detail on that decision, see Prescription vs OTC.
The critical difference between this fading phase and treating PIH in stable skin: sun and heat protection must be maintained at a higher level throughout. The melanocytes have been recently activated. Their threshold for re-stimulation is lower. A single afternoon of unprotected exposure during this phase can undo weeks of topical progress.
For specific ingredient breakdowns, see OTC Topicals for Hyperpigmentation.
What Not to Do
- Do not start aggressive brightening before the trigger is controlled. A vitamin C serum cannot outpace daily unprotected UV. The melanocytes are being activated faster than any topical can suppress them. Protection first.
- Do not assume indoor means safe. Visible light from windows and screens can sustain melanocyte activation, particularly for melasma. UV penetrates window glass (UVA does; UVB does not). Indoor sun protection matters if the indoor environment involves significant light or heat.
- Do not use high-concentration exfoliants on recently UV-sensitised skin. The skin's tolerance is lower than baseline. What worked fine before the sun exposure event may cause irritation now, and irritation triggers melanocyte activity.
- Do not treat heat-triggered pigmentation with heat-based procedures. Laser and IPL deliver thermal energy. If heat is part of the trigger profile, introducing more heat to the skin is counterproductive. This is particularly relevant for melasma that darkens with heat exposure.
- Do not expect the timeline to match PIH from a single event. UV and heat damage is often cumulative. The melanocyte activation may be layered over months or years of exposure. Fading takes longer because the deposits are denser and the melanocytes have been repeatedly stimulated.
For more on how well-intentioned treatments backfire, see Why Some Treatments Make Pigment Worse.
The Internal Layer
UV exposure generates oxidative stress. Heat compounds it. The reactive oxygen species produced by UV damage are among the direct signals that activate melanocytes, and the skin's capacity to neutralise those signals depends partly on systemic antioxidant availability.
For pigmentation that has been driven or worsened by UV and heat, internal antioxidant support addresses one of the specific mechanisms sustaining melanocyte overproduction. It does not replace sunscreen. It influences the oxidative environment that UV creates beneath the surface, influencing how strongly melanocytes respond to the exposure that protection alone cannot fully eliminate.
Hyperpigmentation from within covers those mechanisms in detail.
The Takeaway
UV and heat do not create pigmentation from nothing. They amplify what is already there. They reactivate melanocytes that were settling. They deepen marks that were fading. They are the most common reason pigmentation stalls or worsens despite a consistent topical routine.
The treatment starts with the trigger, not the product. Protection and trigger reduction come first. Stabilisation of the skin comes second. Active fading comes third. That sequence is the difference between a routine that compounds progress and one that keeps resetting itself every time the sun comes out.
